Ewing Morris & Co Investment Partners’s Sotera Health SHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-3,122
Closed -$70.5K 91
2024
Q3
$70.5K Hold
3,122
0.03% 31
2024
Q2
$37.1K Hold
3,122
0.02% 33
2024
Q1
$50.8K Hold
3,122
0.02% 33
2023
Q4
$52.6K Sell
3,122
-7,101
-69% -$101K 0.04% 33
2023
Q3
$153K Sell
10,223
-150,307
-94% -$2.54M 0.12% 26
2023
Q2
$3.02M Buy
160,530
+63,030
+65% +$1M 2.34% 17
2023
Q1
$1.75M Buy
+97,500
New +$1.63M 1.38% 20
2022
Q4
Sell
-320,000
Closed -$2.18M 17
2022
Q3
$2.18M Buy
320,000
+300,000
+1,500% +$4.99M 2.85% 10
2022
Q2
$504K Buy
+20,000
New +$419K 0.34% 16

Other funds holding SHC

Ewing Morris & Co Investment Partners's SHC Position: Q4 2024 in Review

Ewing Morris & Co Investment Partners sold out of Sotera Health (SHC) in Q4 2024, closing a stake of 3,122 shares — an estimated $70.5K sold.

Ewing Morris & Co Investment Partners first reported a position in SHC in Q2 2022 and held it in 9 quarters. The position peaked at $3.02M in Q2 2023. 216 funds tracked by Wall St. Rank hold SHC as of Q4 2024.

  • Ewing Morris & Co Investment Partners reported no remaining Sotera Health position as of Q4 2024 after selling out during the quarter.
  • Ewing Morris & Co Investment Partners sold 3,122 Sotera Health shares in Q4 2024, an estimated $70.5K.
  • Ewing Morris & Co Investment Partners first reported a position in Sotera Health in Q2 2022 and held it in 9 quarters.
  • Ewing Morris & Co Investment Partners's Sotera Health position peaked at $3.02M in Q2 2023.
  • 216 funds tracked by Wall St. Rank held Sotera Health as of Q4 2024.

Based on Ewing Morris & Co Investment Partners's 13F filing for Q4 2024, filed 14 Feb 2025.